Archives of Clinical Infectious Diseases

Published by: Kowsar

Efficiency of Helicobacter pylori Infection Treatment Protocol: Clarithromycin, Amoxicillin and Omeprazole

Parviz Saleh 1 , Armin Zarrintan 2 , 3 , Ali Hossein Zeinal Zade 4 , Reza Piri 2 , 3 , Sahar Mohammadi 3 and Mohammad Naghavi-Behzad 5 , *
Authors Information
1 Infectious and Tropical Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
3 Student Research Committee, Medical Faculty, Tabriz University of Medical Sciences, Tabriz, IR Iran
4 Department of Community Medicine, Medical Faculty, Tabriz University of Medical Sciences, Tabriz, IR Iran
5 Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: December 24, 2012, 8 (1); 14-7
  • Published Online: December 24, 2012
  • Article Type: Research Article
  • Received: September 4, 2012
  • Revised: November 13, 2012
  • Accepted: December 1, 2012
  • DOI: 10.5812/archcid.14408

To Cite: Saleh P, Zarrintan A, Zeinal Zade A H, Piri R, Mohammadi S, et al. Efficiency of Helicobacter pylori Infection Treatment Protocol: Clarithromycin, Amoxicillin and Omeprazole, Arch Clin Infect Dis. 2012 ; 8(1):14-7. doi: 10.5812/archcid.14408.

Copyright © 2012, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J. Harrison's™ Principles of Internal Medicine. 2012;
  • 2. Luther J, Higgins PD, Schoenfeld PS, Moayyedi P, Vakil N, Chey WD. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability. Am J Gastroenterol. 2010; 105(1): 65-73[DOI][PubMed]
  • 3. Franceschi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Minerva Med. 2006; 97(1): 39-45[PubMed]
  • 4. Deron E, Kiec-Swierczynska M. [The role of Helicobacter pyroli in the development of skin diseases]. Med Pr. 2002; 53(4): 333-7[PubMed]
  • 5. Saleh P, Bastani P, Piri R, Goldust M, Naghavi-Behzad M. Antimicrobial prophylaxis for surgical site infections in surgical wards in North-West Iran. Life Sci J. 2013; 10(2): 1977-1981
  • 6. Essa AS, Kramer JR, Graham DY, Treiber G. Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication. Helicobacter. 2009; 14(2): 109-18[DOI][PubMed]
  • 7. Delport W, van der Merwe SW. The transmission of Helicobacter pylori: the effects of analysis method and study population on inference. Best Pract Res Clin Gastroenterol. 2007; 21(2): 215-36[DOI][PubMed]
  • 8. Graham DY, Yamaoka Y, Malaty HM. Thoughts about populations with unexpected low prevalences of Helicobacter pylori infection. Trans R Soc Trop Med Hyg. 2007; 101(9): 849-51[DOI][PubMed]
  • 9. Saleh P, Azari-Yam S, Naghavi-Behzad M. The correspondence between pneumonia severity index (PSI) and quantitative C-Reactive protein in patients with pneumonia. Tabriz U Med Sci Health Serv. 2013; 35(2): 56-63
  • 10. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature. 2007; 445(7130): 915-8[DOI][PubMed]
  • 11. Goodman KJ, Correa P. Transmission of Helicobacter pylori among siblings. The Lancet. 2000; 355(9201): 358-62
  • 12. Egan BJ, Marzio L, O'Connor H, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter. 2008; 13 Suppl 1: 35-40[DOI][PubMed]
  • 13. Chey WD, Wong BC, Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007; 102(8): 1808-25[DOI][PubMed]
  • 14. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007; 56(6): 772-81[DOI][PubMed]
  • 15. Ramteke S, Jain NK. Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori. J Drug Target. 2008; 16(1): 65-72[DOI][PubMed]
  • 16. O'Connor A, Gisbert JP, McNamara D, O'Morain C. Treatment of Helicobacter pylori infection 2011. Helicobacter. 2011; 16 Suppl 1: 53-8[DOI][PubMed]
  • 17. Aminian K, Farsad F, Ghanbari A, Fakhreih S, Hasheminasab SM. A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy. Trop Gastroenterol. 2010; 31(4): 303-7
  • 18. Okada M, Nishimura H, Kawashima M, Okabe N, Maeda K, Seo M, et al. A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome. Aliment Pharm Therap. 1999; 13(6): 769-74[DOI]
  • 19. Zullo A, Vaira D, Vakil N, Hassan C, Gatta L, Ricci C, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharm Therap. 2003; 17(5): 719-26[DOI]
  • 20. Hung IF, Chan P, Leung S, Chan FS, Hsu A, But D, et al. Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong? Helicobacter. 2009; 14(6): 505-11[DOI][PubMed]
  • 21. Sanches B, Coelho L, Moretzsohn L, Vieira G, Jr. Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options. Helicobacter. 2008; 13(6): 572-6[DOI][PubMed]
  • 22. Ghadir MR, Shafaghi A, Iranikhah A, Pakdin A, Joukar F, Mansour-Ghanaei F. Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease. Turk J Gastroenterol. 2011; 22(1): 1-5[PubMed]
  • 23. Fischbach LA, Goodman KJ, Feldman M, Aragaki C. Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis. Int J Epidemiol. 2002; 31(1): 128-39[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments